Clinical trial
A Phase II Multicenter Pilot Study of the Safety and Efficacy of Doxycycline/UrsoDeoxyCholicAcid on Disease Progression in ATTR Amyloidosis
NCT02016365 is registered in ClinicalTrials.gov with Umeå University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Multicenter Pilot Study of the Safety and Efficacy of Doxycycline/UrsoDeoxyCholicAcid on Disease Progression in ATTR Amyloidosis
- Lead sponsor
- Umeå University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 29, 2012
- Completion date
- December 31, 2014
- Enrollment
- 55 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
cardiomyopathy, transthyretin amyloidosis